All Renal conditions articles
-
AnimationPrescribing a dipeptidyl peptidase-4 inhibitor in people with type 2 diabetes and comorbidities
This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.
-
Supplement
Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities
This supplement has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.
-
Sponsored algorithm
Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities
This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited.
-
Key learning points
Key learning points: NICE acute kidney injury
Dr Ivan Benett discusses five key learning points from the recently updated NICE guideline on prevention, detection, and management of acute kidney injury
-
Hot topic
Plasma protein tests: how to interpret abnormal results
Dr Jez Thompson describes the range of plasma protein tests available in primary care and explains what abnormal results might indicate
-
Hot topic
Co-morbidities in type 2 diabetes
Dr Kevin Fernando describes eight common co-morbidities in patients with type 2 diabetes and how the co-existing conditions should be managed
-
Implementing guidelines
Chronic kidney disease audit highlights areas for improvement
Dr Kathryn Griffith summarises some key findings from the National CKD audit and explains why the NICE quality standard should lead to improvements in care
-
News
New and updated quality standards published by NICE
NICE has published Quality Standard (QS) 155 on Low back pain and sciatica in over 16s, and updated QS5 on Chronic kidney disease in adults.
-
NICE quality standard article
People with CKD have a higher risk of cardiovascular events
Dr Ivan Benett explains how implementing the NICE quality standard on chronic kidney disease will help to reduce the number of individuals needing dialysis or renal replacement
-
Implementing guidelines
Aspirational range for haemoglobin level in anaemia of CKD revised
Dr Penny Ackland discusses how trial evidence has led NICE to update the intervention and target haemoglobin levels for people with chronic kidney disease-related anaemia
-
GMS contract
Primary care has an important role in the management of CKD
Dr Kathryn Griffith explains how the chronic kidney disease indicators in the quality and outcomes framework have evolved, and how they fit in with NICE guidance
-
Implementing guidelines
Cardiovascular risk should be reduced in patients with CKD
Dr Alan Begg reviews the guidelines on chronic kidney disease from NICE and SIGN, and highlights key clinical points for management in primary care
-
Implementing guidelines
GPs need to be aware of the risk factors for developing CKD
Dr Ivan Benett outlines the key recommendations from the NICE guideline on chronic kidney disease that can be implemented in primary care
-
Implementing guidelines
New SIGN guideline defines risks for chronic kidney disease patients
Dr Mark MacGregor discusses the recommendations on diagnosis and management of CKD, which highlight greater monitoring and reduction of associated cardiovascular risk
-
Personal view
Chronic kidney disease indicators overlap with other disease areas
Some of your CKD patients will already be managed appropriately because of their current co-morbid conditions, comments Dr Steve Kane-ToddHall
